Dermatology Times, July 2022 (Vol. 43. No. 7)

Approval of a novel oral JAK inhibitor specifically indicated for this challenging condition fills a long unmet need.

An expert offers insights into the who, how, and when of these combined therapies.

David B. Mandell, JD, MBA, and Jason M. O'Dell, MS, CWM examine 4 important success factors dermatologists should implement in their practice when considering a sale or merger.

In this month's Legal Eagle, David J. Goldberg, MD, JD, writes about a difficult legal case involving metastatic melanoma and mole mapping.

Zoe Diana Draelos, MD, discusses a rising trend in the industry—clean and green skin care, in this month's Cosmetic Conundrums column.

Amy Paller, MD, chair of the Department of Dermatology at Northwestern University’s Feinberg School of Medicine, sits down to answer the important questions on this FDA approval.

Parental acne has “significant” associations with presentation and a predisposition to moderate to severe disease, but acne in siblings is a better indicator of the likelihood of grade 3 to 4 scarring, reported a recent study.

A systematic review of literature shows a shift from amputation to other surgical tactics to treat certain types of nail squamous cell carcinomas.

Age alone does not appear to predict all post-treatment outcomes for BCC patients and should not be used solely to guide BCC-related treatment decisions, a recent study says.

Education, honesty, and communication skills are key for both patient and dermatologist when it comes to creating treatment regimens.

In a hard-hitting session from the 2022 Fall Clinical Dermatology Conference for PAs & NPs, April Armstrong, MD, MPH, dove into PAD technology and future innovations in psoriasis treatment.

Learn to discern the best pain-mitigation strategies for each patient, based on research and personal experience.

Patients with chronic inflammatory skin diseases do not have an increased risk of venous thromboembolism (VTE) compared to a matched healthy control cohort. This knowledge can be useful to clinicians when contemplating systemic immunomodulatory therapies in their dermatologic patients.

Data from one study showed younger women more likely to use sunscreen than older adults.

Gina Mangin, PA-C, and James Treat, MD, dive into the intricacies of acne and rosacea, going beyond the surface of both skin conditions and giving important treatment tips at the 2022 New Wave Dermatology Conference.

Theodore Rosen, MD, highlights the need for communication with patients about the potential harm of using skin-whiteners.